Single Bladder Pneumatic Tourniquets Market -Industry Trends and Forecast to 2029
Single Bladder Pneumatic Tourniquets Market -Industry Trends and Forecast to 2029 application (orthopedic, intravenous regional anaesthesia (IVRA), and others) tourniquets-industry Trends and Forecast to 2029 . The Association for Safe International Road Travel (ASIRT) estimates that every year on U.S. roads, approximately 38,000 people pass away and an additional 4.4 million suffer severe injuries. The increasing prevalence of orthopaedic issues among the population as a result of insufficient physical activity and sedentary lifestyles is driving up demand for pneumatic tourniquets on a global scale. Additionally, the market is being stimulated by increasing demand for pneumatic tourniquets as well as the development of novel products by industry players.
Single Bladder Pneumatic Tourniquet Market Analysis and Size
The Association for Safe International Road Travel (ASIRT) estimates that every year on U.S. roads, approximately 38,000 people pass away and an additional 4.4 million suffer severe injuries. The increasing prevalence of orthopaedic issues among the population as a result of insufficient physical activity and sedentary lifestyles is driving up demand for pneumatic tourniquets on a global scale. Additionally, the market is being stimulated by increasing demand for pneumatic tourniquets as well as the development of novel products by industry players.
Regional Analysis/Insights for the Single Bladder Pneumatic Tourniquet Market
The single-bladed pneumatic tourniquet market is analysed and market size insights and trends are provided by country, type, and application as referenced above. The countries covered in the single bladder pneumatic tourniquet market report are the U.S., Canada and Mexico in North America; Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe; China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC); Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and the Rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA); Brazil, Argentina; and the rest of South America as part of South America. North America dominates the single bladder pneumatic tourniquet market due to the increasing geriatric population across the region, healthcare infrastructure, and better reimbursement policies.
Report Scope and Market Segmentation for Single Bladder Pneumatic Tourniquet
2022-2029 Forecast Period
2021 is the base year.
Historic Years 2020 (Can be customised to 2014-2019)
Quantitative Units Revenue in billions of dollars, volume in units, and pricing in dollars.
Type (single bladder, double bladder), tourniquet, application (orthopaedic, intravenous regional anaesthesia (IVRA), others) are all covered.
Request Access for Digital OOH Market Sample Report: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-single-bladder-pneumatic-tourniquet-market
Single Bladder Pneumatic Tourniquet Market Analysis at the Country Level
The countries covered in the single bladder pneumatic tourniquet market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and the Rest of Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina; and the rest of South America as part of South America. North America dominates the single bladder pneumatic tourniquet market due to the increasing geriatric population across the region, healthcare infrastructure, and better reimbursement policies.
Competitive Landscape and Single bladder pneumatic tourniquet Market Share Analysis
The single bladder pneumatic tourniquet market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance.
The major players operating in the single bladder pneumatic tourniquet market are
- Bohua Medical (China)
- Hpm (U.S.)
- Hangzhou Zhengda (China)
- DS MAREF (South Korea)
- Ulrich Medical (Germany)
- SMEF (India)
- Huifeng Medical (China)
- VBM (U.S.)
- AneticAid (U.K.)
- Hema Medical (U.S.)
- Zimmer Biomet (U.S.)
- D & D (U.S.)
- Stryker (U.S.)
Access Full Report : https://www.databridgemarketresearch.com/reports/global-single-bladder-pneumatic-tourniquet-market
Major TOC of the Digital Out of Home Advertising Report
Chapter One: Introduction
Chapter Two: Market Segmentation
Chapter Three: Market Overview
Chapter Four: Executive Summary
Chapter Five: Premium Insights
Chapter Six: Global Brain Monitoring Market by Product & Procedure type
Get TOC of the Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-single-bladder-pneumatic-tourniquet-market
Browse Related Reports @
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
The global pneumatic nebulizers market size was valued at USD 490.6 million in 2015 and is expected to reach a value of USD 893.9 million by 2025.
For instance, in May 2013, Parion Sciences in partnership with Cambridge Consultants developed a technology that delivers tiny saline droplets that infiltrate deep into the lungs.
The trans-nasal pulmonary aerosol delivery device currently undergoing clinical trial is intended for the treatment of cystic fibrosis.Moreover, with the rising rate of hospital admissions and the resultant high expenditure, companies are encouraged to introduce home care devices that enable pre-hospitalization monitoring.
Furthermore, the advent of integrated devices has empowered patients and physicians to share and access data on a single platform.For instance, in March 2016, Philips received 510 (K) clearance for its Care Orchestrator.
The cloud-based technology is a clinical management software, which promotes homecare for sleep apnea and respiratory care patients.
Moreover, the clinical management system furnishes a single platform combining sleep and respiratory care, providing informatics and workflow intelligence for patients, providers, and payers.Some of the major players operating include Omron Corporation, Philips Healthcare; PARI Pharma GmbH; GE Healthcare; Allied Healthcare; Becton, Dickinson and Company; Agilent Technologies; Medline Industries, Inc.; and Briggs Healthcare.Further Key Findings from the Study Suggest:Vented nebulizers dominated the product type segment in 2015 owing to their high availability and affordable cost.
